ABSTRACT In 75 unselected and untreated patients with small cell carcinoma of the lung, plasma ACTH, serum calcitonin, and antidiuretic hormone (ADH) in plasma and urine were related to corresponding clinical symptoms and biochemical findings at the time of diagnosis. The significance of elevated concentrations of these substances in relation to treatment was also investigated. Plasma ACTH concentrations were increased in 22 patients (29%), and 25 patients (33%) were considered to have inappropriate ADH secretion. Only one patient had definite hypokalaemic alkalosis, and one patient pronounced hyponatraemia, with associated clinical syndromes of ectopic ACTH and ADH secretion. Serum calcitonin concentrations were increased in 48 patients (65%). No related clinical symptoms were disclosed, and all these patients had normal serum calcium concentrations. Thirty-three of 66 patients (50%) had raised levels of free cortisol in a 24-hour urine and these levels were significantly related to plasma ACTH concentrations. The median survival was slightly shorter in patients with increased values of the three substances, but this was not related to increased plasma ACTH concentrations and was not statistically significant. Survival rates and results of treatment were independent of the pretreatment levels of the three substances.
had normal serum calcium concentrations. Thirty-three of 66 patients (50%) had raised levels of free cortisol in a 24-hour urine and these levels were significantly related to plasma ACTH concentrations. The median survival was slightly shorter in patients with increased values of the three substances, but this was not related to increased plasma ACTH concentrations and was not statistically significant. Survival rates and results of treatment were independent of the pretreatment levels of the three substances.
Ectopic production of ACTH and ADH in malignant tumours is well documented, and usually occurs in relation to small cell carcinoma of the lung (scc). [1] [2] [3] Recently the production of calcitonin in scc has also been documented. [4] [5] [6] While no clinical signs related to hypercalcitonaemia have been observed, clinical syndromes have been related to the ectopic production of ACTH and ADH.2 7 8 In a review of 138 cases with scc Kato et a19 found Cushing's syndrome in 2-8% of the patients. Investigating 41 treated and untreated patients with scc Gilby et alPO found increased concentrations of plasma cortisol before and after dexamethasone suppression in half of the patients, but only three were considered to have the ACTH syndrome. The inappropriate ADH syndrome (SIADH) is claimed to occur in up to 20% of patients with scc," and Gilby et al,10 using water loading, found an overall prevalence in about 40% of their sample. Both ACTH12-14 and ADH15 appear to be produced in almost all cases of scc.
We have studied ectopic ACTH, ADH, and calcitonin production at the time of diagnosis in 75 unselected patients with scc. The relationships between these three substances, their clinical features, and the implications for response to treatment and survival have been investigated.
Methods
The study included 75 18 Before starting chemotherapy or radiotherapy or both two 24-hour urine samples were collected, the second being acidified with 10 ml 0'1 HCl. Between these two collections a fasting blood sample was collected. Blood was taken on ice and centrifuged at 40C immediately, and plasma and serum were kept below -200C until analysis.
Plasma ACTH19 and serum calcitonin20 were measured by radioimmunoassay techniques. Two samples for analysis of plasma ACTH were obtained with a 10-minute interval, and the lower value was used (in healthy control subjects 76 ng/ l=mean+2 SD).
Arginine-vasopressin (ADH) was measured by radioimmunoassay in acidified urine21 and in plasma. 22 Analyses on urine were attempted in the first 46 patients, but a sample was not obtained in five patients. If frozen plasma was available, analysis were performed in patients with raised urine ADH or decreased plasma osmolality or both, thereby including 31 patients, 15 of whom had also urine ADH measured.
In the first 24-hour urine sample free cortisol,23 ketogenic steroids (KGS),2' creatinine, and osmolality were measured. Routine plasma analyses were performed for osmolality, sodium, chloride, potassium, standard bicarbonate, calcium, and phosphorus.
Results

ACTH
None of the patients had the physical signs of Cushing's syndrome and only one was clinically suspected of ectopic ACTH production because of oedema, polyuria, and thirst. This patient also had hypokalaemic alkalosis (K : 2-2 mmol/l, HCO3-: 34-2 mmol/l) and a plasma ACTH of 199 ng/l. Five other patients had hypokalaemia, the lowest value being 2'8 mmol/l. Serum bicarbonate in these five patients ranged from to 29*5 mmol/l. Plasma ACTH concentrations were above 76 ng/l in 22 patients (29%-95% confidence limits: 19-41%). The highest value, 199 ng/l, was obtained in the above-mentioned patient, while the remaining results had values below 157 ng/l. The median value of ACTH in all patients was 64 ng/l, twice the median value in healthy control subjects.19 Thirty-three of 66 patients (50%) had increased urinary excretion of free cortisol, including 18 of 47 patients (36%) with plasma ACTH below 76 ng/l, and 15 of 19 patients (79%) with plasma ACTH above 76 ng/l.
The median value of urinary cortisol was 726 nmol/24 hours (range: 468-13 500) in the 18 patients with plasma ACTH below 76 ng/l, and 750 nmol/l (range: 455-10 020) in the 15 patients with plasma ACTH above 76 ng/l. Only nine patients (14%) had significantly increased ketogenic steroids, and eight of these also had increased free cortisol. The patient with increased ketogenic steroids and normal free cortisol had an increased plasma ACTH, while eight patients with raised plasma ACTH and free cortisol had normal ketogenic steroid levels. ANTIDIURETIC 
HORMONE
Only one patient was clinically suspected of SIADH because of lethargy, weakness, and oliguria. This patient had hyponatraemia (Na+: 123 mmol/l), hypotonic plasma with higher urine osmolality (plasma: 244 and urine 345 mosmol/kg H20), and inappropriately increased concentrations of urine ADH (34 mU/l) and plasma ADH (3*1 pg/ml). Eleven more patients had plasma sodium between 132 and 135 mmol/l. Altogether, 32 patients (43%) had hypotonic plasma (osmolality below 280 mosmol/kg H20). In only two of these patients was the osmolality of urine below that of plasma. Urine ADH was measured in 15 18 Survival data for these patients with regard to the level of the three substances are given in table 3. The median survival was somewhat longer for patients with normal levels of each of the three hormones and for patients with no increased levels, compared to patients with increases of the respective substance and patients with two or three increased substances, but none of these differences was statistically significant. Considering the long-term results, the proportions of patients surviving more than one year, and the number of patients still alive without treatment and free of disease are almost identical (table 3) . There is a slight increase in long-term survival in patients without inappropriate ADH secretion as well as for patients with none of the three substances raised, but these differences are not statistically significant.
Discusion
The finding of Cushing's syndrome in a middleaged man might very well be the result of small cell carcinoma, thereby indicating a diagnostic value,3 26 though the present results show that the 
